Rocket Pharmaceuticals, Inc. (RCKT) Deep Dive Video
Summary
Rocket’s first FDA approval de-risks the platform and unlocks PRV-funded runway—now the stock is a leveraged bet on a safe, reimbursable cardiology gene-therapy breakthrough in Danon Disease.